299 related articles for article (PubMed ID: 32077359)
21. Minority Participation in Biobanks: An Essential Key to Progress.
Kim P; Milliken EL
Methods Mol Biol; 2019; 1897():43-50. PubMed ID: 30539433
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics and individualized medicine: translating science into practice.
Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
Sing CW; Cheung CL; Wong IC
Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
[TBL] [Abstract][Full Text] [Related]
24. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenomics, precision medicine, and implications for anesthesia care.
Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
[TBL] [Abstract][Full Text] [Related]
26. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
[TBL] [Abstract][Full Text] [Related]
27. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics in the clinic.
Relling MV; Evans WE
Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings.
Sukasem C; Jantararoungtong T; Koomdee N
Drug Metab Pharmacokinet; 2021 Aug; 39():100399. PubMed ID: 34098253
[TBL] [Abstract][Full Text] [Related]
30. Significance of Pharmacogenomics in Precision Medicine.
Cascorbi I
Clin Pharmacol Ther; 2018 May; 103(5):732-735. PubMed ID: 29660122
[TBL] [Abstract][Full Text] [Related]
31. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
Hoffman JM; Haidar CE; Wilkinson MR; Crews KR; Baker DK; Kornegay NM; Yang W; Pui CH; Reiss UM; Gaur AH; Howard SC; Evans WE; Broeckel U; Relling MV
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):45-55. PubMed ID: 24619595
[TBL] [Abstract][Full Text] [Related]
32. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.
Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ
Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317
[No Abstract] [Full Text] [Related]
33. Pharmacogenomics and personalized medicine in clinical practice.
Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
[TBL] [Abstract][Full Text] [Related]
34. Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer.
Kanakoglou DS; Pampalou A; Vrachnos DM; Karatrasoglou EA; Zouki DN; Dimonitsas E; Klonou A; Kokla G; Theologi V; Christofidou E; Sakellariou S; Lakiotaki E; Piperi C; Korkolopoulou P
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35169862
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics knowledge for personalized medicine.
Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
Blagec K; Swen JJ; Koopmann R; Cheung KC; Crommentuijn-van Rhenen M; Holsappel I; Konta L; Ott S; Steinberger D; Xu H; Cecchin E; Dolžan V; Dávila-Fajardo CL; Patrinos GP; Sunder-Plassmann G; Turner RM; Pirmohamed M; Guchelaar HJ; Samwald M;
PLoS One; 2022; 17(6):e0268534. PubMed ID: 35675343
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
38. A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT.
Liu M; Vnencak-Jones CL; Roland BP; Gatto CL; Mathe JL; Just SL; Peterson JF; Van Driest SL; Weitkamp AO
Clin Pharmacol Ther; 2021 Jan; 109(1):101-115. PubMed ID: 33048353
[TBL] [Abstract][Full Text] [Related]
39. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
[TBL] [Abstract][Full Text] [Related]
40. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
